CAS 181225-33-2

(20E)-Ginsenoside F4

Formula: C₄₂H₇₀O₁₂

InChI: InChI=1S/C42H70O12/c1-20(2)11-10-12-21(3)23-13-16-41(8)29(23)24(44)17-27-40(7)15-14-28(45)39(5,6)36(40)25(18-42(27,41)9)52-38-35(33(49)31(47)26(19-43)53-38)54-37-34(50)32(48)30(46)22(4)51-37/h11-12,22-38,43-50H,10,13-19H2,1-9H3/b21-12+/t22-,23+,24+,25-,26+,27+,28-,29-,30-,31+,32+,33-,34+,35+,36-,37-,38+,40+,41+,42+/m0/s1

InChI key: QOMBXPYXWGTFNR-PWAOTOFHSA-N

SMILES: C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@H]3C[C@@]4([C@H](C[C@H]([C@H]5[C@]4(CC[C@@H]5/C(=C/CC=C(C)C)/C)C)O)[C@@]6([C@@H]3C([C@H](CC6)O)(C)C)C)C)CO)O)O)O)O)O

Synonyms:

• Ginsenoside F4

(2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethyl-17-((E)-6-methylhepta-2,5-dien-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-6-yl

CAS: 181225-33-2

(2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethyl-17-((E)-6-methylhepta-2,5-dien-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-6-yl

Formula: C₄₂H₇₀O₁₂

Purity: 98%

Molecular weight: 767.01

Ref: 54-OR1067143

(20E)-Ginsenoside F4

CAS: 181225-33-2

Formula: C₄₂H₇₀O₁₂

Molecular weight: 767.01

Ref: 7W-GY1701

Ginsenoside F4

CAS: 181225-33-2

Ginsenoside F4 induces apoptosis in JK cells via mitochondrial dysfunction, Bax upregulation, and Bcl-2 downregulation, leading to cell death.

Formula: C₄₂H₇₀O₁₂

Purity: 97.20% - 97.33%

Color and Shape: Solid

Molecular weight: 767.01

Ref: TM-TN1093

Ginsenoside F4 (Standard)

CAS: 181225-33-2

Ginsenoside F4 (Standard) is a reference standard for research and analysis in studies involving Ginsenoside F4. Ginsenoside F4 exerts inhibitory effects on human lymphocytoma JK cells by inducing apoptosis. The mechanism of action involves mitochondrial dysfunction, increased Bax expression, and reduced Bcl-2 expression, together resulting in programmed cell death.

Formula: C₄₂H₇₀O₁₂

Color and Shape: Solid

Molecular weight: 767.01

Ref: TM-TMSM-0004

(20E)-Ginsenoside F4

CAS: 181225-33-2

Formula: C₄₂H₇₀O₁₂

Purity: 95%~99%

Molecular weight: 767.01

Ref: BP-BP0656

Ginsenoside F4

CAS: 181225-33-2

(2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethyl-17-((E)-6-methylhepta-2,5-dien-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol

Formula: C₄₂H₇₀O₁₂

Purity: 98%

Molecular weight: 767.0

Ref: IN-DG766153

(E)-Ginsenoside F4

Controlled Product

CAS: 181225-33-2

Formula: C₄₂H₇₀O₁₂

Color and Shape: Neat

Molecular weight: 767.0

Ref: TR-G410265

(E)-Ginsenoside F4

CAS: 181225-33-2

(E)-Ginsenoside F4 is a bioactive compound, specifically a type of saponin, which is derived from the root of the Panax ginseng plant. This compound is structurally characterized by its steroidal backbone with sugar moieties, which is common among ginsenosides. The mode of action of (E)-Ginsenoside F4 involves modulation of various signaling pathways, including anti-inflammatory, antioxidant, and neuroprotective mechanisms. These pathways are influenced through the inhibition of NF-κB activation and the protection against oxidative stress, which can lead to a decrease in inflammatory cytokines and an increase in cellular resilience.

Formula: C₄₂H₇₀O₁₂

Purity: Min. 95%

Molecular weight: 767 g/mol

Ref: 3D-GHA22533